OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-11.9%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$402M
AUM Growth
+$402M
(-13%)
Cap. Flow
+$4.55M
Cap. Flow
% of AUM
1.13%
Top 10 Holdings %
Top 10 Hldgs %
96.63%
Holding
17
New
1
Increased
6
Reduced
4
Closed
1
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$4.46M |
| 2 |
Opko Health
OPK
|
$4.44M |
| 3 |
AGEN
Agenus
AGEN
|
$1.03M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$964K |
| 5 |
DERM
Dermira, Inc.
DERM
|
$471K |
Top Sells
| 1 |
Cigna
CI
|
$4.67M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$1.41M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$703K |
| 4 |
AXDX
Accelerate Diagnostics
AXDX
|
$153K |
| 5 |
QuidelOrtho
QDEL
|
$49.1K |
Sector Composition
| 1 | Healthcare | 97.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $109M | 26.93% |
1,784,464
-800
| -0% | -$49.1K |
|
|
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
| $80.7M | 19.86% |
4,348,140
-8,223
| -0.2% | -$153K |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $76.3M | 18.78% |
5,036,220
-92,750
| -2% | -$1.41M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $74.3M | 18.26% |
1,779,875
+106,925
| +6% | +$4.46M |
|
|
5
Opko Health
OPK
$1.1B
| $12.1M | 2.99% |
5,810,376
+2,124,182
| +58% | +$4.44M |
|
|
DERM
6
DELISTED
Dermira, Inc.
DERM
| $11.7M | 2.88% |
1,833,785
+73,713
| +4% | +$471K |
|
|
MOTS
7
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $7.54M | 1.85% |
3,806,666
+40,000
| +1% | +$79.2K |
|
8
Soleno Therapeutics
SLNO
$3.6B
| $5.81M | 1.43% |
3,870,627
+57,069
| +1% | +$85.6K |
|
9
Pacific Biosciences
PACB
$393M
| $5.73M | 1.41% |
1,110,666
| – | – |
|
|
VRML
10
DELISTED
Vermillion, Inc.
VRML
| $5.13M | 1.26% |
9,825,289
| – | – |
|
|
BIOL
11
DELISTED
Biolase, Inc.
BIOL
| $4.86M | 1.2% |
5,173,250
| – | – |
|
|
AGEN
12
Agenus
AGEN
$133M
| $4.67M | 1.15% |
1,808,296
+399,378
| +28% | +$1.03M |
|
|
CFRX
13
DELISTED
ContraFect Corporation
CFRX
| $1.57M | 0.39% |
4,392,713
-1,963,936
| -31% | -$703K |
|
14
Biogen
BIIB
$19.4B
| $1.48M | 0.36% |
6,368
| – | – |
|
|
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
| $964K | 0.24% |
+288,237
| New | +$964K |
|
|
16
Cigna
CI
$80.3B
| – | – |
-29,653
| Closed | -$4.67M |
|
17
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|